Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. PNR
2. ONON
3. IAUX
4. KKR
5. DAVA
6. MONC:IM
7. MONRY
8. NYXH
9. THO
10. JG

Go back to Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide
REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 58.44 --0 (-0%)
Previous Close $58.44    52 Week High $3.48 
Open $58.44    52 Week Low $0.80 
Day High $58.44    P/E N/A 
Day Low $58.44    EPS $-1.54 
Volume 13       

(NASDAQ: ZEAL) Delayed: 17.59 --0 (-0%)
Previous Close $17.59    52 Week High $ 
Open $1.35    52 Week Low $ 
Day High $17.59    P/E N/A 
Day Low $17.59    EPS $ 
Volume 15,962       

(NASDAQ: ZEAL) Delayed: 17.59 --0 (-0%)
Previous Close $17.59    52 Week High $ 
Open $1.35    52 Week Low $ 
Day High $17.59    P/E N/A 
Day Low $17.59    EPS $ 
Volume 15,962